SCHEMBL19903504

SCHEMBL19903504

N#Cc1cc(-n2c3ccccc3c3ccc(C(F)(F)F)cc32)c(-n2c3ccccc3c3ccc(C(F)(F)F)cc32)cc1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.44
MAT2A P31153 4/20 0.35
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CTSS P25774 1/20 0.33
CNR2 P34972 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HSP90AA1 P07900 1/20 0.32
AR P10275 1/20 0.32
XDH P47989 1/20 0.32
TRPA1 O75762 1/20 0.32
TAS2R14 Q9NYV8 1/20 0.32
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22564564 0.95 KIF11 (0.41) KIF11MAT2AALOX5APFEN1TSHR
SCHEMBL19903506 0.94 KIF11 (0.37) KIF11MAT2AALOX5APFEN1TSHR
SCHEMBL19903532 0.94 KIF11 (0.41) KIF11MAT2ATSHRSMN1; SMN2AR
SCHEMBL19903505 0.93 KIF11 (0.39) KIF11ALOX5APFEN1TSHRSMN1; SMN2
SCHEMBL19903672 0.93 KIF11 (0.44) KIF11MAT2AALOX5APFEN1TSHR
SCHEMBL19912577 0.93 KIF11 (0.43) KIF11MAT2AALOX5APFEN1TSHR
SCHEMBL22822146 0.92 KIF11 (0.39) KIF11MAT2AALOX5APFEN1TSHR
SCHEMBL19917991 0.91 AR (0.35) KIF11ARTRPA1SCN9A
SCHEMBL20925148 0.91 KIF11 (0.34) KIF11KDM4EARXDHTRPA1
SCHEMBL19903606 0.91 AR (0.35) KIF11ARTRPA1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 KIF11 3253/4885MAT2A 2881/4885ALOX5AP 3371/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KIF11 3316/4885MAT2A 2653/4885ALOX5AP 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.